医学
终末期肾病
并发症
血运重建
血管通路
外围设备
动脉疾病
血管疾病
外科
阶段(地层学)
结束语(心理学)
肾动脉
血管闭合器
肱动脉
放射科
心脏病学
内科学
股动脉
血液透析
肾
血压
古生物学
市场经济
心肌梗塞
经济
生物
作者
Yu‐Ying Lu,Ying‐Chang Tung,Ming-Yun Ho,Jiun‐Ting Yeh,Cheng-Hung Lee,Hsin-Fu Lee,Shing-Hsien Chou,Chao-Yung Wang,Chun‐Chi Chen,Ming‐Lung Tsai
标识
DOI:10.1177/15385744241239492
摘要
Objectives Manual compression (MC) or vascular closure devices (VCDs) are used to achieve hemostasis after percutaneous transluminal angioplasty (PTA). However, limited data on the comparative safety and effectiveness of VCDs vs MC in patients with end-stage renal disease (ESRD) undergoing PTA are available. Accordingly, this study compared the safety and effectiveness of VCD and MC in patients with ESRD undergoing PTA. Methods This single-center retrospective cohort study included the data of patients with ESRD undergoing peripheral intervention at Chang Gung Memorial Hospital, Taiwan, from January 1, 2019, to June 30, 2022. The patients were divided into VCD and MC groups. The primary endpoint was a composite of puncture site complications, including acute limb ischemia, marked hematoma, pseudoaneurysm, and puncture site bleeding requiring blood transfusion. Results We included 264 patients with ESRD undergoing PTA, of whom 60 received a VCD and 204 received MC. The incidence of puncture site complications was 3.3% in the VCD group and 4.4% in the MC group (hazard ratio: .75; 95% confidence interval: .16-3.56 L P = 1.000), indicating no significant between-group difference. Conclusion VCDs and MC had comparable safety and effectiveness for hemostasis in patients with ESRD undergoing peripheral intervention.
科研通智能强力驱动
Strongly Powered by AbleSci AI